mutLBSgeneDB |
Gene summary for DPYSL2 |
![]() |
Basic gene Info. | Gene symbol | DPYSL2 |
Gene name | dihydropyrimidinase-like 2 | |
Synonyms | CRMP-2|CRMP2|DHPRP2|DRP-2|DRP2|N2A3|ULIP-2|ULIP2 | |
Cytomap | UCSC genome browser: 8p22-p21 | |
Type of gene | protein-coding | |
RefGenes | NM_001197293.2, NM_001244604.1,NM_001386.5, | |
Description | collapsin response mediator protein hCRMP-2dihydropyrimidinase-related protein 2unc-33-like phosphoprotein 2 | |
Modification date | 20141207 | |
dbXrefs | MIM : 602463 | |
HGNC : HGNC | ||
Ensembl : ENSG00000092964 | ||
HPRD : 03914 | ||
Vega : OTTHUMG00000099439 | ||
Protein | UniProt: Q16555 go to UniProt's Cross Reference DB Table | |
Expression | CleanEX: HS_DPYSL2 | |
BioGPS: 1808 | ||
Pathway | NCI Pathway Interaction Database: DPYSL2 | |
KEGG: DPYSL2 | ||
REACTOME: DPYSL2 | ||
Pathway Commons: DPYSL2 | ||
Context | iHOP: DPYSL2 | |
ligand binding site mutation search in PubMed: DPYSL2 | ||
UCL Cancer Institute: DPYSL2 | ||
Assigned class in mutLBSgeneDB | C: This gene just belongs to mutLBSgenes. |
![]() |
GO ID | GO Term | PubMed ID |
Top |
Ligand binding site mutations for DPYSL2 |
![]() |
LBS | AAchange of nsSNV | Cancer type | # samples | E353 | P352L | UCEC | 1 |
cf) Cancer type abbreviation. BLCA: Bladder urothelial carcinoma, BRCA: Breast invasive carcinoma, CESC: Cervical squamous cell carcinoma and endocervical adenocarcinoma, COAD: Colon adenocarcinoma, GBM: Glioblastoma multiforme, LGG: Brain lower grade glioma, HNSC: Head and neck squamous cell carcinoma, KICH: Kidney chromophobe, KIRC: Kidney renal clear cell carcinoma, KIRP: Kidney renal papillary cell carcinoma, LAML: Acute myeloid leukemia, LUAD: Lung adenocarcinoma, LUSC: Lung squamous cell carcinoma, OV: Ovarian serous cystadenocarcinoma, PAAD: Pancreatic adenocarcinoma, PRAD: Prostate adenocarcinoma, SKCM: Skin cutaneous melanoma, STAD: Stomach adenocarcinoma, THCA: Thyroid carcinoma, UCEC: Uterine corpus endometrial carcinoma. |
Top |
Protein structure related information for DPYSL2 |
![]() Mupro score denotes assessment of the effect of mutations on thermodynamic stability. (ΔΔE<0: mutation decreases stability, ΔΔE>0: mutation increases stability) |
![]() ![]() |
![]() |
![]() Blue: mutations of positive stability change. and red : the most recurrent mutation for this gene. |
LBS | AAchange of nsSNV | Relative stability change | E353 | P352L | -0.83207607 |
(MuPro1.1: Jianlin Cheng et al., Prediction of Protein Stability Changes for Single-Site Mutations Using Support Vector Machines, PROTEINS: Structure, Function, and Bioinformatics. 2006, 62:1125-1132) |
![]() |
Top |
Differential gene expression and gene-gene network for DPYSL2 |
![]() |
![]() |
Top |
Top |
Phenotype information for DPYSL2 |
![]() |
Disease ID | Disease name | # PubMed | Association type |
umls:C0002395 | Alzheimer Disease | 3 | Biomarker, PostTranslationalModification |
umls:C0036349 | Schizophrenia, Paranoid | 2 | Biomarker, GeneticVariation |
umls:C0029408 | Osteoarthritis | 1 | Biomarker |
![]() |
Allele ID | AA change | Clinical significance | Origin | Phenotype IDs |
Top |
Pharmacological information for DPYSL2 |
![]() Heatmap showing the correlation between gene expression and drug response across all the cell-lines. We chose the top 20 among 138 drugs.We used Pearson's correlation coefficient. |
![]() |
![]() |
Drug status | DrugBank ID | Name | Type | Drug structure |
![]() |
![]() |
![]() |
Ligand ID | Ligand short name | Ligand long name | PDB ID | PDB name | mutLBS | MG | MAGNESIUM(2+) | 2vm8 | A | E353 |
Top |
Conservation information for LBS of DPYSL2 |
![]() |
LBS | AA sequence | # species | Species | E353 | FTLIPEGTNGT | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | Q81 | FQMPDQGMTSA | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus | T349 | GKDNFTLIPEG | 4 | Homo sapiens, Bos taurus, Mus musculus, Rattus norvegicus |
![]() |
Copyright © 2016-Present - The University of Texas Health Science Center at Houston |